Registration Statement

Indaptus Therapeutics, Inc. Filed 2022-12-23 Acc 0001493152-22-036488

Documents 1

2024-09-12 S-1 Registration Statement
2022-12-30 EFFECT Notice of Effectiveness
2022-12-29 UPLOAD SEC-generated Letter
2022-12-23 S-1 Registration Statement
2022-12-23 8-K Material agreement · Unregistered share sale
2022-12-19 4 Chief Medical Officer bought 1,150 shares at an average $2.19 ($2,520)
2021-09-24 S-1 Registration Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading forms-1.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…